查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439666

可吸收止血剂 - 全球市场回顾、竞争格局、市场预测（2030）

Absorbable Hemostats - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

在预测期（2024-2030年），全球可吸收止血剂市场规模预计将以 6.47% 的复合年增长率成长。 由于脊椎疾病盛行率上升、手术期间患者出血控制日益受到关注以及产品开发中的技术创新等因素，该市场呈现正增长，导致2024-2030年预测期内吸收量增加。止血剂市场。

可吸收止血剂市场动态

由于各种原因，可吸收止血剂市场的产品需求不断增长，影响市场成长的主要因素之一是脊椎疾病盛行率的上升。

根据世界卫生组织 (WHO) 的数据，2020 年全球约有 17.1 亿人可能患有肌肉骨骼疾病。

上述资料显示，2020年，腰痛是肌肉骨骼疾病中负担最大的，全球患有此病的人数达5.68亿人。

根据世界卫生组织 (WHO) (2022) 的数据，肌肉骨骼疾病是全球残疾的主要原因，而腰痛是 160 个国家/地区残疾的主要原因。

此外，交通事故和跌倒等创伤的增加更有可能导致脊椎损伤，进一步增加了对可吸收止血剂的需求。

根据世界卫生组织（WHO）（2022）发布的数据，全球每年有25万至50万人遭受脊髓损伤（SCI），其中大部分脊髓损伤是由交通事故造成的。

此外，根据Nogo Inhibition in Spinal Cord Injury的数据，2020年欧盟每年将新增约10,000例脊髓损伤病例，按正常预期寿命计算，2020年将有超过200,000名患者遭受脊髓损伤。欧盟，承受损害。

因此，由于上述因素，全球对能够使运动损伤和脊髓疾病早期恢復的可吸收止血剂的需求不断增加，导致全球可吸收止血剂市场的整体增长。

因此，所有上述因素都预测可吸收止血剂在未来几年的扩张，并有助于可吸收止血剂市场在 2024-2030 年预测期内的增长。

然而，缺乏熟练使用可吸收止血剂的专业人员以及可吸收止血剂的高成本可能是可吸收止血剂市场增长的一定限制因素。

史无前例的 COVID-19 爆发对可吸收止血剂市场产生了重大影响。 在 COVID-19 大流行期间，封锁规定减少了患者就诊次数，并暂时中止了所有其他外科手术，以确保更多关注 COVID-19 患者。确实如此。 但各类疫苗的上市已恢復正常运行，带动了疫情后可吸收止血剂市场的成长。

可吸收止血剂细分市场分析

在可吸收止血剂市场的製剂领域，预计在 2024-2030 年预测期内，基质凝胶止血剂将占可吸收止血剂市场的主要占有率。 这可能是由于它在手术过程中能够适应伤口轮廓并填充深层病变。

Matrix已被证明是一种更有效的止血剂，与其他止血剂相比，显示出更快的止血速度和更好的治疗效果。

此外，研究表明，使用基质凝胶止血剂可以减少术后併发症、减少再次手术、减少输血和缩短手术时间。

此外，各种形式的明胶的重要特性是它们能够吸收超过自身重量 40 倍的血液和体液，并且能够在体内体积膨胀 200%。 这意味着明胶形式比基于胶原蛋白或再生氧化纤维素的局部止血剂增加的体积更多。

因此，基质凝胶止血剂比其他製剂製剂更优越。 因此，所有上述因素都可能在预测期内推动可吸收止血剂市场中基质凝胶类别的成长。

本报告研究和分析了全球可吸收止血剂市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章可吸收止血器市场报告简介

第2章可吸收止血剂市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第3章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章可吸收止血剂市场主要因素分析

  • 推动可吸收止血剂市场的因素
    • 脊椎疾病的盛行率不断上升
    • 越来越关注手术期间病患的出血控制
    • 产品开发中的技术创新
  • 可吸收止血剂市场的限制与挑战
    • 缺乏熟练使用可吸收止血产品的专业人员
    • 可吸收止血剂成本高
  • 可吸收止血剂市场机会
    • 生物外科可吸收止血产品越来越受欢迎
    • 推出针对新兴市场的产品

第5章可吸收止血剂市场波特五力分析

第6章COVID-19对可吸收止血剂市场的影响分析

第7章可吸收止血剂市场布局

  • 依类型
    • 基于凝血酶的止血剂
    • 氧化再生纤维素系止血剂
    • 明胶止血剂
    • 胶原蛋白止血剂
    • 其他
  • 按配方剂
    • 基质凝胶止血剂
    • 海绵止血钳
    • 粉末止血剂
  • 依用途
    • 颅神经外科
    • 骨科手术
    • 一般外科
    • 重建手术
  • 按最终用户
    • 医院、诊所
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第8章可吸收止血剂市场：全球公司占有率分析 - 3至5家主要公司

第9章可吸收止血剂市场公司及产品概况

  • B.Braun
  • Baxter
  • Johnson & Johnson
  • BD
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed
  • Hangzhou Singclean Medical Products
  • Teleflex Incorporated
  • Hemostasis, LLC
  • Stryker
  • Samyang Holdings Corporation

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

Product Code: DIMDCL0506

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of spinal ailments and rapid technological developmental activities in product arena

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030). The absorbable hemostats market is witnessing positive growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

Absorbable Hemostats Market Dynamics:

The Absorbable Hemostats market is witnessing a growth in product demand owing to various reasons, one of the major factors influencing the growth of the absorbable hemostats market is the rising incidence of spinal ailments.

According to the World Health Organization 2022, in 2020 approximately 1.71 billion people tend to suffer from musculoskeletal conditions worldwide.

Report Metrics

Details

Study Period

2021 to 2030

Base Year

2022

Forecast Period

2024 to 2030

CAGR

6.47%

Market Size

--

Key Companies

B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, and others

As per the aforementioned source, in the year 2020 among musculoskeletal disorders, lower back pain had caused the highest-burden with a prevalence of 568 million people worldwide.

According to the World Health Organization 2022, musculoskeletal conditions are a leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries.

Moreover, a rise in traumatic injuries due to road crashes falls, and others are likely to cause spine injuries which will further increase the demand for Absorbable Hemostats.

As per the data published by the World Health Organization 2022, every year between 250,000 and 500,000 people suffer a spinal cord injury (SCI) around the world and the majority of spinal cord injuries are due to road traffic crashes, falls, or violence.

Additionally, the Nogo Inhibition in Spinal Cord Injury, in the year 2020, the incidence of spinal cord injury is about 10'000 newly injured people per year in the EU, and due to a normal life expectancy, more than 200,000 patients are living with a spinal cord injury in the EU.

Therefore, owing to the abovementioned factors, there is a growing need for absorbable hemostats in the market globally which allows faster recovery of sports-related injuries and spinal ailments, thereby leading to the overall growth of the global absorbable hemostats market.

Hence, all the above-mentioned factors are projected to augment for Absorbable Hemostats in the forthcoming years, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

However, the dearth of skilled professionals for effective use of absorbable hemostat products and the high cost of the absorbable hemostats may be certain limiting factors of the Absorbable Hemostats market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for absorbable hemostats. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19 inflicted patient. However, the launch of various vaccines has resumed normal operations further leading to the growth of the Absorbable Hemostats market during the post-pandemic.

Absorbable Hemostats Market Segment Analysis:

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Formulants segment of the Absorbable Hemostats market, the Matrix & Gel Hemostats are estimated to hold a significant share in the Absorbable Hemostats market during the forecast period from 2024-2030. This can be attributed to the fact that in surgery, they can conform to wound contours and fill deep lesions.

The matrix is proven to be a more effective hemostat, demonstrating faster hemostasis and better outcomes compared with other formulants of hemostatic agents.

Moreover, research also indicates that the use of Matrix & Gel Hemostats is associated with fewer post-surgical complications, surgical revisions, and blood transfusions, as well as shorter surgical times.

Furthermore, an important property of the different forms of gelatin is its ability to absorb more than 40 times its weight in blood and fluids and its ability to expand its volume by 200% in vivo. This means that gelatin forms increase their volume more than the topical hemostatics based on collagen and regenerated oxidized cellulose.

Therefore, the advantages associated with Matrix & Gel Hemostats compared to other formulants. Thus, all the aforementioned factors are likely to propel the matrix & gels category growth in the absorbable hemostats market during the forecast period.

North America is expected to dominate the overall Absorbable Hemostats Market:

Among all the regions, North America is expected to account for the largest share in the Global Absorbable Hemostats market. The growing number of spine-related disorders among others will also increase the absorbable hemostats market in the United States.

Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

For instance, the National Spinal Cord Injury Statistical Center 2019, the United States population size of 328 million people worldwide. Also, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year.

Furthermore, according to the Miami Project 2020, in the year 2020, approximately 17,810 new spinal cord injuries each year in the US. Also, as per the aforementioned source, males account for about 78% of the new spinal cord injuries cases.

A rising focus on blood loss management in patients during surgeries will lead to an increase in the demand for absorbable hemostats, thereby leading to traction in the overall absorbable hemostats market.

Moreover, product approvals pertaining to absorbable hemostats will also lead to an increase in the demand for absorbable hemostats, thereby leading to an overall increase in the absorbable hemostat market.

For instance, on February 23, 2022, FDA had approved EndoClot® Hemostat to Manage GI Bleeding. EndoClot® PHS is a single-use device including a starch-based powder hemostat that is applied directly to the bleeding site through a flexible endoscope.

Thus, the interplay of all the aforementioned factors is likely to fuel the market growth of absorbable hemostats in the United States during the forecast period.

Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Absorbable Hemostats. Also, advanced product launches and commercialization agreements among the key companies are further expected to fuel the market.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market for Absorbable Hemostats during the forecasted period.

Absorbable Hemostats Market Key Players:

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, and others.

Recent Developmental Activities in the Absorbable Hemostats Market:

On March 25, 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, announced the strategic regional launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.

On January 09, 2018, Ethicon announced the US launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT, a powdered adjunctive hemostat that was designed to help surgeons control disruptive bleeding more efficiently.

Key Takeaways from the Absorbable Hemostats Market Report Study

Market size analysis for current Absorbable Hemostats market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Absorbable Hemostats market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Absorbable Hemostats market.

Various opportunities available for the other competitor in the Absorbable Hemostats market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Absorbable Hemostats market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Absorbable Hemostats market growth in the coming future?

Target Audience who can be benefited from this Absorbable Hemostats Market Report Study

Absorbable Hemostats products providers

Research organizations and consulting companies

Absorbable Hemostats-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Absorbable Hemostats

Various End-users who want to know more about the Absorbable Hemostats market and latest technological developments in the Absorbable Hemostats market.

Frequently Asked Questions for Absorbable Hemostats Market:

1. What are Absorbable Hemostats?

Absorbable Hemostats are used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

2. What is the market for Global Absorbable Hemostats?

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030).

3. What are the drivers for Global Absorbable Hemostats Market?

The Absorbable Hemostats market is witnessing a positive market growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development.

4. Who are the key players operating in the Global Absorbable Hemostats Market?

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation and others.

5. Which region has the highest share in Absorbable Hemostats Market?

North America is expected to hold the highest share in the revenue in the Absorbable Hemostats market during the forecast period. The growing number of sports-related injuries and the rising number of spine-related disorders among others will also increase the absorbable hemostats market. Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

Table of Contents

1.Absorbable Hemostats Market Report Introduction

2.Absorbable Hemostats Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Absorbable Hemostats Market Key Factors Analysis

  • 4.1. Absorbable Hemostats Market Drivers
    • 4.1.1. Rising Incidence of Spinal Ailments
    • 4.1.2. Rising Focus on Blood Loss Management in Patients During Surgeries
    • 4.1.3. Technological Innovation in Product Development
  • 4.2. Absorbable Hemostats Market Restraints and Challenges
    • 4.2.1. The dearth of Skilled Professionals for Effective Use of Absorbable Hemostat Products
    • 4.2.2. High Cost of the Absorbable Hemostats
  • 4.3. Absorbable Hemostats Market Opportunities
    • 4.3.1. Rising Popularity of Biosurgical Absorbable Hemostat Product
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Absorbable Hemostats Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Absorbable Hemostats Market

7. Absorbable Hemostats Market Layout

  • 7.1. By Type
    • 7.1.1. Thrombin-Based Hemostats
    • 7.1.2. Oxidized Regenerated Cellulose-Based Hemostats
    • 7.1.3. Gelatin-Based Hemostats
    • 7.1.4. Collagen-Based Hemostats
    • 7.1.5. Others
  • 7.2. By Formulants
    • 7.2.1. Matrix & Gel Hemostats
    • 7.2.2. Sponge Hemostats
    • 7.2.3. Powder Hemostats
    • 7.2.4. Others
  • 7.3. By Application
    • 7.3.1. Neurosurgery
    • 7.3.2. Orthopedic Surgery
    • 7.3.3. General Surgery
    • 7.3.4. Reconstructive Surgery
    • 7.3.5. Others
  • 7.4. By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Absorbable Hemostats Market, by Type
      • 7.5.1.2. North America Absorbable Hemostats Market, by Formulants
      • 7.5.1.3. North America Absorbable Hemostats Market, by Application
      • 7.5.1.4. North America Absorbable Hemostats Market, by End User
      • 7.5.1.5. North America Absorbable Hemostats Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Absorbable Hemostats Market, by Type
      • 7.5.2.2. Europe Absorbable Hemostats Market, by Formulants
      • 7.5.2.3. Europe Absorbable Hemostats Market, by Application
      • 7.5.2.4. Europe Absorbable Hemostats Market, by End User
      • 7.5.2.5. Europe Absorbable Hemostats Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Absorbable Hemostats Market, by Type
      • 7.5.3.2. Asia-Pacific Absorbable Hemostats Market, by Formulants
      • 7.5.3.3. Asia-Pacific Absorbable Hemostats Market, by Application
      • 7.5.3.4. Asia-Pacific Absorbable Hemostats Market, by End User
      • 7.5.3.5. Asia-Pacific Absorbable Hemostats Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Absorbable Hemostats Market, by Type
      • 7.5.4.2. RoW Absorbable Hemostats Market, by Formulants
      • 7.5.4.3. RoW Absorbable Hemostats Market, by Application
      • 7.5.4.4. RoW Absorbable Hemostats Market, by End User
      • 7.5.4.5. RoW Absorbable Hemostats Market, by Region
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Absorbable Hemostats Market Global Company Share Analysis - Key 3-5 Companies

9. Absorbable Hemostats Market Company and Product Profiles

  • 9.1. B.Braun
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Baxter
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Johnson & Johnson
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. BD
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cura Medical
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. GELITA MEDICAL
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Curasan AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Meril Life Sciences
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Zhonghui Shengxi
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Beijing Datsing Bio-tech
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Guizhou Jin Jiu Biotech
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Beijing Taikesiman
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Foryou Medical
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Saikesaisi Holdings Group
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Biotemed
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Hangzhou Singclean Medical Products
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Teleflex Incorporated
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Hemostasis, LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Stryker
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Samyang Holdings Corporation
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Absorbable Hemostats Market in Global (2021-2030)
  • Table 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Table 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Table 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Table 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Table 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Table 9: Absorbable Hemostats Market in North America (2021-2030)
  • Table 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Table 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Table 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Table 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Table 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Table 15: Absorbable Hemostats Market in the US (2021-2030)
  • Table 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Table 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Table 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Table 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Table 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Table 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Table 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Table 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Table 24: Absorbable Hemostats Market in France (2021-2030)
  • Table 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Table 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Table 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Table 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Table 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Table 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Table 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Table 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Table 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Table 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Table 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Table 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Table 37: Absorbable Hemostats Market in China (2021-2030)
  • Table 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Table 39: Absorbable Hemostats Market in India (2021-2030)
  • Table 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Table 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Table 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Table 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Table 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Table 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Table 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Table 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Table 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Table 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Table 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Table 51: Absorbable Hemostats Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Absorbable Hemostats Market in Global (2021-2030)
  • Figure 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Figure 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Figure 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Figure 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Figure 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Figure 9: Absorbable Hemostats Market in North America (2021-2030)
  • Figure 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Figure 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Figure 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Figure 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Figure 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Figure 15: Absorbable Hemostats Market in the US (2021-2030)
  • Figure 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Figure 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Figure 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Figure 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Figure 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Figure 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Figure 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Figure 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Figure 24: Absorbable Hemostats Market in France (2021-2030)
  • Figure 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Figure 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Figure 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Figure 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Figure 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Figure 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Figure 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Figure 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Figure 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Figure 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Figure 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Figure 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Figure 37: Absorbable Hemostats Market in China (2021-2030)
  • Figure 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Figure 39: Absorbable Hemostats Market in India (2021-2030)
  • Figure 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Figure 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Figure 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Figure 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Figure 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Figure 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Figure 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Figure 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Figure 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Figure 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Figure 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Figure 51: Absorbable Hemostats Market in South America (2021-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Marker Opportunities
  • Figure 55: PORTER'S Five Force Analysis